|
|
|
|
| LEADER |
00000cam a22000001i 4500 |
| 001 |
SCIDIR_on1353785713 |
| 003 |
OCoLC |
| 005 |
20231120010717.0 |
| 006 |
m d |
| 007 |
cr ||||||||||| |
| 008 |
220701s2023 maua o 001 0 eng d |
| 040 |
|
|
|a UKMGB
|b eng
|e rda
|e pn
|c UKMGB
|d YDX
|d UKAHL
|d OPELS
|d OCLCF
|d N$T
|d OCLCO
|
| 015 |
|
|
|a GBC2C3735
|2 bnb
|
| 016 |
7 |
|
|a 020678175
|2 Uk
|
| 019 |
|
|
|a 1344370828
|a 1352001028
|
| 020 |
|
|
|a 0323885985
|q (ePub ebook) :
|
| 020 |
|
|
|a 9780323885980
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323899536
|q (pbk.)
|
| 020 |
|
|
|z 0323899536
|
| 035 |
|
|
|a (OCoLC)1353785713
|z (OCoLC)1344370828
|z (OCoLC)1352001028
|
| 050 |
|
4 |
|a R857.N34
|
| 082 |
0 |
4 |
|a 610.28
|2 23
|
| 245 |
0 |
0 |
|a Design and applications of theranostic nanomedicines /
|c edited by Somasree Ray, Amit Kumar Nayak.
|
| 264 |
|
1 |
|a Cambridge, MA :
|b Woodhead Publishing,
|c 2023.
|
| 300 |
|
|
|a 1 online resource :
|b illustrations (black and white, and colour).
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 336 |
|
|
|a still image
|2 rdacontent
|
| 337 |
|
|
|a computer
|2 rdamedia
|
| 338 |
|
|
|a online resource
|2 rdacarrier
|
| 490 |
1 |
|
|a Woodhead Publishing series in biomaterials
|
| 500 |
|
|
|a <p><b>Section I: Introduction to Theranostic Nanomedicines</b> 1. Theranostic nanostructures as nanomedicines: Challenges, costs and benefits</p> <p><b>Section II: Design</b> 2. Nanodispersions: Design and theranostic applications 3. Theranostic nanogels: Design and applications 4. Exosomes: A novel tool for diagnosis and therapy 5. Engineered liposomes as drug delivery and imaging agents 6. Polymeric micelles for theranostic uses 7. Dendrimers: An effective drug delivery and therapeutic approach 8. Nanocochelate: An advanced theranostic tool</p> <p><b>Section III: Applications</b> 9. Theranostic applications of nanoemulsions in pulmonary diseases 10. Polymeric nanoparticles as tumor-targeting theranostic platform 11. Site-specific theranostic uses of simuli responsive nanohydrogels 12. Ligand appended theranostic nanocarriers for targeted blood brain barrier 13. Nanotheranostics in CNS malignancy 14. Nanotheranostic approaches in the treatment of neurological disorders 15. Applications of nanotheranostic medicines to treat cancers</p> <p><b>Section IV: Toxicology and Future</b> 16. Nanotheranostics: The toxicological implication 17. The Future of Nanotheranostics</p>
|
| 500 |
|
|
|a Includes index.
|
| 588 |
|
|
|a Description based on CIP data; resource not viewed.
|
| 650 |
|
0 |
|a Nanomedicine.
|
| 650 |
|
2 |
|a Nanomedicine
|0 (DNLM)D050997
|
| 650 |
|
6 |
|a Nanom�edecine.
|0 (CaQQLa)201-0448752
|
| 650 |
|
7 |
|a Nanomedicine
|2 fast
|0 (OCoLC)fst01744350
|
| 700 |
1 |
|
|a Ray, Somasree,
|e editor.
|
| 700 |
1 |
|
|a Nayak, Amit Kumar,
|d 1979-
|e editor.
|1 https://isni.org/isni/0000000500070559
|
| 776 |
0 |
8 |
|i Print version:
|z 9780323899536
|
| 830 |
|
0 |
|a Woodhead Publishing series in biomaterials.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323899536
|z Texto completo
|
